Pathogenesis and neuroprotective treatment in Purtscher's retinopathy

Japanese Journal of Ophthalmology

Volumn 42, Issue 4, 1998, Pages 318-322

  Wang, An Guor ^a   Yen, May Yung ^a,b   Liu, Jorn Hon ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Indocyanine green angiography; Megadose steroid; Purtscher's retinopathy

Indexed keywords

INDOCYANINE GREEN;

ADOLESCENT; ARTICLE; CASE REPORT; CHOROID VASCULARIZATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; NEUROPROTECTION; OPTIC NERVE; PATHOGENESIS; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINOPATHY; TRAFFIC ACCIDENT; VISUAL IMPAIRMENT;

ACCIDENTS, TRAFFIC; ACUTE DISEASE; ADOLESCENT; CERVICAL VERTEBRAE; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; INFUSIONS, INTRAVENOUS; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; RETINAL DISEASES; RETINAL VESSELS; SPINAL FRACTURES; VISUAL ACUITY;

EID: 0032123052     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(98)00015-X     Document Type: Article

References (25)

1. 1. Purtscher O. Noch unbekannte Befunde nach Schaedeltrauma. Ber Dtsch Ophthalmol Ges 1910;36:294-310.
2. 2. Kelly JS. Purtscher's retinopathy related to chest compression by safety belts. Fluorescein angiographic findings. Am J Ophthalmol 1972;72:278-83.
3. 3. Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment. 3rd ed: St. Louis, MO: The CV Mosby Company, 1987.
4. 4. Roden D, Fitzpatrick G, O'Donoghue H, Phelan D. Purtscher's retinopathy and fat embolism. Br J Ophthalmol 1989;73:677-9.
5. 5. Lemagne JM, Michiels X, Causenbroeck SV, Snyers B. Purtscher-like retinopathy after retrobulbar anesthesia. Ophthalmology 1990;97:859-61.
6. 6. Toshniwal PK, Berman AA, Axelrod AJ. Purtscher's retinopathy secondary to pancreatitis. J Clin Neuro-Ophthalmol 1986;6(3):160-5.
7. 7. Blodi BA, Johnson MW, Gass JDM, Fine SL, Joffe LM. Purtscher's-like retinopathy after childbirth. Ophthalmology 1990;97:1654-9.
8. 8. Atabay C, Kansu T, Nurlu G. Late visual recovery after intravenous methylprednisolone treatment of Purtscher's retinopathy. Ann Ophthalmol 1993;25:330-3.
9. 9. Shibata K, Furuki I, Saitoh Y et al. A case of Purtscher's retinopathy. Am J Emer Med 1994;12:661-3.
10. 10. Kelly JS, Dhalinwal RS. Traumatic chorioretinopathy. In: Ryan S, eds. Retina. 2nd ed. St. Louis, MO: The CV Mosby Company, 1994:1783-96.
11. 11. Burton TC. Unilateral Purtscher's retinopathy. Ophthalmology 1980;87:1096-105.
12. 12. Kincaid MC, Green WR, Knox DL, Mohler C. A clinico-pathological case report of retinopathy of pancreatitis. Br J Ophthalmol 1982;66:219-26.
13. 13. DeVoe AG. Ocular fat embolism. A clinical and pathologic report. Trans Am Ophthalmol Soc 1949;47:254-62.
14. 14. Gomez-Ulla F, Fente B, Torreiro MG et al. Choroidal vascular abnormality in Purtscher's retinopathy shown by indocyanine green angiography. Am J Ophthalmol 1996;122:261-3.
15. 15. Chuang EL, Kalina RE. Purtscher's retinopathy. In: Gold DH, Weingeist TA, eds. The eye in systemic disease. Philadelphia: JB Lippincott, 1990:474-7.
16. 16. Jacob HS, Goldstein IM, Shapiro L et al. Sudden blindness in acute pancreatitis, possible role of complement-induced retinal leukoembolization. Arch Intern Med 1981;141:134-6.
17. 17. Jacob HS, Craddock PR, Hammerschmidt DE et al: Complement-induced granulocyte aggregation; an unsuspected mechanism of disease. N Engl J Med 1980;302:789-94.
18. 18. Abramson S, Belmont HM, Hokins P et al. Complement activaiton and vascular injury in systemic lupus erythematosus. J Rheum 1987;14 Suppl 13:43-6.
19. 19. Craddock PR, Hammerschmidt DE, White JG, Palmasso AP, Jacob HS. Complement (C5a)-induced granulocyte aggregation in vitro: a possible mechanism of complement mediated leukostasis and leukopenia. J Clin Invest 1977;60:260-4.
20. 20. Scheurer G, Pruetorius G, Damerau B, Behrens-Baumann W. Vascular occlusion of the retina: an experimental model. I. Leukocyte aggregates. Graefes Arch Clin Exp Ophthalmol 1992;230:275-80.
21. 21. Sacks T, Moldow CF, Craddock PR et al. Oxygen radicals endothelial cell damage by complement stimulated granulocyte: an in vitro model of immune vascular damage. J Clin Invest 1978;61:1161-7.
22. 22. Frayser R, Hickam JB. Effect of vasodilator drugs on the retinal blood flow in man. Arch Ophthalmol 1965;73:640-2.
23. 23. Matzkin DC, Slamovits TL, Sachs R et al. Visual recovery in two patients after intravenous methylprednisolone treatment of central retinal artery occlusion secondary to giant-cell arteritis. Ophthalmology 1992;99:68-71.
24. 24. Hammerschmidt DE, White JG, Craddock PR et al. Inhibition of complement (C5a)-induced granulocyte (PMN) aggregation; a possible mechanism for the efficacy of corticosteroids in shock and the adult respiratory distress syndrome (ARDS). J Clin Invest 1979;63:798-803.
25. 25. Goldstein IM, Roos D, Weisman G et al. Influence of corticosteroid on human polymorphonuclear leukocyte function in vitro: reaction of lysosomal enzyme release and superoxide production. Inflammation 1976;1:305-15.